Prevalence of the metabolic syndrome among Italian adults. Findings from the SIMAP study;Prevalenza della sindrome metabolica in una zona territoriale della Regione Marche

Recenti Progressi in Medicina

Volumn 96, Issue 6, 2005, Pages 280-283

  Magi, Lorenzo ^a   Stramenga, Carlo ^a   Morosini, Pierpaolo ^b,c  

^a Medicina Generale   (Italy)

^b Ospedale C e G Mazzoni   (Italy)

^c NONE   (Italy)

Author keywords

Cardiovascular disease; Metabolic syndrome; Type 2 diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 22844451704     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. National Institutes of Health. Third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda: National Institutes of Health; 2001. NIH Publication 01-3670.
2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
3. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005; 111: 1985-91.
4. Dagogo-Jack S. Primary prevention of cardiovascular disease in pre-diabetes: the glass is half full and half empty. Diabetes Care 2005; 28: 971-2.
5. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21: 360-7.
6. Bjornholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E. Fasting blood glucose: an underestimated risk factor for cardiovascular death: results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 1999; 22: 45-9.
7. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 124 years. Diabetes Care 1999; 22: 233-40.
8. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-4.
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
10. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2003; 163: 427-36.
11. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004; 15: 2816-27.
12. Di Nardo F, Casagrande F, Boemi M, Fumelli P, Morosini P, Burattini R. Insulin resistance in hypertension quantified by oral glucose tolerance test: comparison of methods. Metabolism (in corso di pubblicazione).
13. Ford ES, Kohl HW, III, Mokdad AH, Ajani UA. Sedentary behavior, physical activity, and the metabolic syndrome among US. Adults Obesity Research 2005; 13: 608-14.
14. Ng MCY, So WY, Lam VKL, Cockram CS, Bell GI, Cox NJ, Chan JCN. Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 2004; 53: 2676-83.
15. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, for the Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial. Ann Intern Med 2005; 142: 611-9.
16. Hawkins MA. Markers of increased cardiovascular risk: are we measuring the most appropriate parameters? Obesity Research 2004; 12: 107S-114S
17. Del Toma E. La dieta si fa contando i passi. Meno diete, più movimento. Roma: Il Pensiero Scientifico Editore 2004.
18. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27: s11-s14.